NCT01784380View on ClinicalTrials.gov

The Potential Biochemical Diagnosis Criteria and Therapeutic Effect Indexes: Sex Hormone Binding Globulin Levels and Free Androgen Index in Blood of Patients With Polycystic Ovary Syndrome

CompletedOBSERVATIONAL
Enrollment

1,159

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
The Investigators Collected 534 PCOS Patients as the Case Group,and 580 Infertile Women With Normal Ovulatory Cycle of the Control Group;At the Same Time, the Investigators Continuedly Collect Cases to October 2012, and Totally Collected 579 Patients With PCOS Altogether;534 Patients in the Cases Group and 580 Women in the Control Group Received no Measures, While 579 Patients Received Drugs;The Investigators Monitored Basic Indexes in Blood of All the Subjects in This Suvey,and Also Monitored Indexes of 579 Patients After Treatment.
Interventions
DRUG

Diane-35;metformin;Clomiphene citrate; Human menopausal gonadotropin

Trial Locations (2)

528400

Elecsys2010,French KONTRON EUB-5500 color Doppler ultrasonic diagnostic apparatus, Zhongshan

528403

Reproductive Center of Bo Ai Hospital, Zhongshan, Zhongshan

All Listed Sponsors
lead

Zhongshan Bo Ai Hospital

OTHER

NCT01784380 - The Potential Biochemical Diagnosis Criteria and Therapeutic Effect Indexes: Sex Hormone Binding Globulin Levels and Free Androgen Index in Blood of Patients With Polycystic Ovary Syndrome | Biotech Hunter | Biotech Hunter